Buy 2C-I (hydrochloride) online
2C-T-2, also known as 2,5-dimethoxy-4-ethylthiophenethylamine, is an entheogen and psychedelic phenethylamine from the 2C family. It was first synthesized by Alexander Shulgin in 1981. The substance has structural and pharmacological properties similar to those of mescaline, MDMA (ecstasy), and 2C-T-7.
effects of 2C-T-2
The effects of 2C-T-2 are similar to those of 2C-T-7, although 2C-T-2 is more likely to cause a pronounced "body sensation" and other strange reactions, including skin rashes and a feeling of heated walls. The effects begin about an hour after ingestion and last for about two hours. Hallucinations similar to those of LSD, psilocybin and other serotonin hallucinogens, are quite pronounced at typical doses of 2C-T-2. For strong psychedelic effects, it is recommended to take around 30 mg, with the threshold being around 10 mg.
Pharmaceutical properties
The exact mechanism underlying the hallucinogenic and entheogenic effects of 2C-T-2 is still unknown. However, it is believed to act as a 5-HT2A serotonin receptor agonist in the brain. This receptor interaction is crucial for the hallucinogenic effects and connects 2C-T-2 to other psychedelics. The substance has remarkable potential in research.
Risks and Safety
The toxicity of 2C-T-2 is not well documented. Although it is much weaker than 2C-T-7, it may exhibit similar levels of toxicity to other phenethylamines at higher doses. Combining it with stimulants can be dangerous and lead to fatal serotonin syndrome. Taking 2C-T-2 is also risky for people taking certain medications. Psychedelika and their risks should therefore be carefully considered.
Legal regulations
In the Netherlands, 2C-T-2 has been classified as a dangerous drug and added to Schedule I of the Opium Act in April 1999. In the United States, 2C-T-2 is neither listed nor regulated, but could be prosecuted under the Federal Analog Act. In the United Kingdom, 2C-T-2 and all other compounds contained in PiHKAL are illegal substances.
Reviews
There are no reviews yet.